KMDA
Price
$6.71
Change
-$0.12 (-1.76%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
306.49M
83 days until earnings call
ZTS
Price
$161.98
Change
+$0.54 (+0.33%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
77.48B
81 days until earnings call
Interact to see
Advertisement

KMDA vs ZTS

Header iconKMDA vs ZTS Comparison
Open Charts KMDA vs ZTSBanner chart's image
Kamada
Price$6.71
Change-$0.12 (-1.76%)
Volume$657
Capitalization306.49M
ZOETIS
Price$161.98
Change+$0.54 (+0.33%)
Volume$56.58K
Capitalization77.48B
KMDA vs ZTS Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. ZTS commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a StrongBuy and ZTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (KMDA: $6.83 vs. ZTS: $161.44)
Brand notoriety: KMDA: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 86% vs. ZTS: 98%
Market capitalization -- KMDA: $306.49M vs. ZTS: $77.48B
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 7 TA indicator(s) are bullish while ZTS’s TA Score has 6 bullish TA indicator(s).

  • KMDA’s TA Score: 7 bullish, 2 bearish.
  • ZTS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than ZTS.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -3.12% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.10%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than ZTS: KMDA (37.43) vs ZTS (32.94). KMDA YTD gains are higher at: 15.365 vs. ZTS (-0.280). ZTS has higher annual earnings (EBITDA): 3.67B vs. KMDA (22.4M). ZTS has more cash in the bank: 2.04B vs. KMDA (55.6M). KMDA has less debt than ZTS: KMDA (8.82M) vs ZTS (6.76B). ZTS has higher revenues than KMDA: ZTS (8.54B) vs KMDA (143M).
KMDAZTSKMDA / ZTS
Capitalization306M77.5B0%
EBITDA22.4M3.67B1%
Gain YTD15.365-0.280-5,495%
P/E Ratio37.4332.94114%
Revenue143M8.54B2%
Total Cash55.6M2.04B3%
Total Debt8.82M6.76B0%
FUNDAMENTALS RATINGS
KMDA vs ZTS: Fundamental Ratings
KMDA
ZTS
OUTLOOK RATING
1..100
821
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4750
P/E GROWTH RATING
1..100
4266
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (70) in the Biotechnology industry is in the same range as ZTS (71) in the Pharmaceuticals Generic industry. This means that KMDA’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (69) in the Pharmaceuticals Generic industry is in the same range as KMDA (100) in the Biotechnology industry. This means that ZTS’s stock grew similarly to KMDA’s over the last 12 months.

ZTS's SMR Rating (100) in the Pharmaceuticals Generic industry is in the same range as KMDA (100) in the Biotechnology industry. This means that ZTS’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's Price Growth Rating (47) in the Biotechnology industry is in the same range as ZTS (50) in the Pharmaceuticals Generic industry. This means that KMDA’s stock grew similarly to ZTS’s over the last 12 months.

KMDA's P/E Growth Rating (42) in the Biotechnology industry is in the same range as ZTS (66) in the Pharmaceuticals Generic industry. This means that KMDA’s stock grew similarly to ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDAZTS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 9 days ago
66%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 11 days ago
67%
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX18.32N/A
N/A
Allspring Large Cap Core Inst
CSCZX49.15N/A
N/A
Columbia Small Cap Value I Inst
SESGX23.08N/A
N/A
Sit ESG Growth S
DHIIX19.14N/A
N/A
Diamond Hill International I
ATHWX20.08N/A
N/A
American Century Heritage R

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and CRDL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.58%
CRDL - KMDA
30%
Poorly correlated
-5.36%
RDY - KMDA
29%
Poorly correlated
-1.17%
OGI - KMDA
28%
Poorly correlated
-0.74%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
+1.59%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-1.35%
VTRS - ZTS
41%
Loosely correlated
-4.50%
AMRX - ZTS
37%
Loosely correlated
-2.02%
PAHC - ZTS
37%
Loosely correlated
-3.49%
ELAN - ZTS
36%
Loosely correlated
-3.52%
PBH - ZTS
36%
Loosely correlated
-3.59%
More